Table 1.

Baseline demographic and clinical characteristics, circulating endothelial cells, plasma levels of VWF and IL-6 in acute coronary syndrome, stable coronary artery disease, and healthy control subjects




Acute coronary syndrome, n = 156

Stable CAD, n = 36

Control subjects, n = 40
Age, y, mean ± SD   65 ± 12   60 ± 12   60 ± 8  
Male, n (%)   110 (71)   26 (72)   27 (68)  
BMI, kg/m2, mean ± SD   27 ± 4   27 ± 4   28 ± 5  
Active smoker, n (%)   54 (35)   5 (13)   4 (10)  
Systolic BP, mm Hg, mean ± SD   131 ± 18   136 ± 23   135 ± 16  
Cholesterol, mmol/L, mean ± SD   5.7 ± 0.9   3.6 ± 0.7   5.6 ± 0.7  
HDL-C, mmol/L, mean ± SD   1.0 ± 0.1   1.3 ± 0.2   1.4 ± 0.1  
Creatinine, μmol/L, mean ± SD   89 ± 23   88 ± 17   79 ± 17  
Glucose, mmol/L, mean ± SD   7.4 ± 2.9   6.2 ± 2.6   5.0 ± 0.7  
Research indexes     
    VWF, IU/dL, mean ± SD   215 ± 59   147 ± 32   121 ± 20  
    IL-6, pg/mL, median (IQR)   27.2 (12.8-61.7)   13.4 (8.2-27.7)   10.4 (6.9-14.7)  
    CECs, cells/mL, median (IQR)
 
10.63 (5.75-14.5)
 
3.13 (2.25-4.0)
 
2.75 (1.56-3.94)
 



Acute coronary syndrome, n = 156

Stable CAD, n = 36

Control subjects, n = 40
Age, y, mean ± SD   65 ± 12   60 ± 12   60 ± 8  
Male, n (%)   110 (71)   26 (72)   27 (68)  
BMI, kg/m2, mean ± SD   27 ± 4   27 ± 4   28 ± 5  
Active smoker, n (%)   54 (35)   5 (13)   4 (10)  
Systolic BP, mm Hg, mean ± SD   131 ± 18   136 ± 23   135 ± 16  
Cholesterol, mmol/L, mean ± SD   5.7 ± 0.9   3.6 ± 0.7   5.6 ± 0.7  
HDL-C, mmol/L, mean ± SD   1.0 ± 0.1   1.3 ± 0.2   1.4 ± 0.1  
Creatinine, μmol/L, mean ± SD   89 ± 23   88 ± 17   79 ± 17  
Glucose, mmol/L, mean ± SD   7.4 ± 2.9   6.2 ± 2.6   5.0 ± 0.7  
Research indexes     
    VWF, IU/dL, mean ± SD   215 ± 59   147 ± 32   121 ± 20  
    IL-6, pg/mL, median (IQR)   27.2 (12.8-61.7)   13.4 (8.2-27.7)   10.4 (6.9-14.7)  
    CECs, cells/mL, median (IQR)
 
10.63 (5.75-14.5)
 
3.13 (2.25-4.0)
 
2.75 (1.56-3.94)
 

BMI indicates body mass index; HDL-C, high density lipoprotein cholesterol; CAD, coronary artery disease; VWF, von Willebrand factor; IL-6, interleukin-6; CEC, circulating endothelial cells.

Close Modal

or Create an Account

Close Modal
Close Modal